跳至主要内容
临床试验/NCT04279496
NCT04279496Enrolling By Invitation不适用

Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter

Cleerly, Inc.2 个研究点 分布在 1 个国家目标入组 15,000 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
Cleerly, Inc.
入组人数
15,000
试验地点
2
主要终点
Coronary CT Angiography EvaluatioN For Clinical Outcomes

研究概览

简要总结

The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.

详细描述

CONFIRM2 is a retrospective and prospective, open-label, international, multicenter observational registry designed to evaluate associations between CCTA imaging findings and clinical presentation (cross-sectional) and their ability to predict mortality and major adverse cardiac events (longitudinal) in patients with chronic CAD.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years
  • Undergoing clinically indicated CCTA with >64-detector row CT
  • Signed informed consent, including of release of medical information, long term follow-up and Health Insurance Portability and Accountability Act (HIPAA) documentation

排除标准

  • Individuals unable to provide informed consent
  • Non-cardiac illness with life expectancy < 2 years
  • Pregnancy

结局指标

主要结局

Coronary CT Angiography EvaluatioN For Clinical Outcomes

时间窗: June 2020- June 2022

Examined the totality of information visualized by coronary CT angiography (CCTA) for optimal refinement of prognostic risk stratification

次要结局

未报告次要终点

研究者

发起方
Cleerly, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验